AzTrials
AzTrials

StrokePhase 2/3NCT00849303

Multicenter Rehabilitation Study in Acute Stroke

A Phase 2/3 study testing gait-oriented rehabilitation in people with Stroke, run by University of Jyvaskyla at 4 sites in Finland.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of the first part of this study is to understand plastic brain mechanisms associated with successful gait-oriented stroke rehabilitation. Patients are randomized to receive intensive in-patient multiprofessional rehabilitation at different time points. Read more about this study

Who is it for?
Ages 55 years and older
Conditions the study is for
Stroke
What is being tested?
gait-oriented rehabilitation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
4 sitesFinland
Study dates
Jan 2009to Dec 2011
Phase
Phase 2/3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 55 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • first supratentorial stroke or no significant disturbance from an earlier stroke (Modified Ranking Scale, MRS 0-2)
  • time since onset of stroke no more than 10 days
  • Functional Ambulatory Category (FAC) 0-3
  • voluntary movement in the leg of the affected side
  • Barthel Index (BI) 25-75 points- no unstable cardiovascular disease
  • Body Mass Index (BMI) <32
Show all 9Show fewer
  • no severe malposition of joints
  • no severe cognitive or communicative disorders
  • no other health-related or social barriers to participate intensive rehabilitation

Who cannot join

  • ICH, or MRS >2
  • time since onset of stroke more than 10 days
  • FAC >3
  • no voluntary movement in the leg of the affected side
  • BI <25 or >75
  • severe malposition of joints
  • severe cognitive or communicative disorders

Trial locations and contacts

4 sites in 1 country.

Sinikka H Peurala, PhD, PT contact

+358 14 260 2196

sinikka.h.peurala@jyu.fi

Finland4 sites, 4 recruiting
  • Middle Finland central hospital and Kinkomaa hospital

    Jyväskylä, 40100

    Not yet recruiting
  • Kuopio University Hospital

    Kuopio, 70211

    Recruiting
  • Brain Research and Rehabilitation Center Neuron

    Kuopio, 71130

    Recruiting
  • Tampere university hospital

    Tampere, 33520

    Not yet recruiting

Other trials in Finland

About this study

Official title: Gait-Oriented Rehabilitation at Different Phases in Patients With Acute Stroke - Multicenter Randomized Controlled Trial.

The purpose of the first part of this study is to understand plastic brain mechanisms associated with successful gait-oriented stroke rehabilitation. Patients are randomized to receive intensive in-patient multiprofessional rehabilitation at different time points. One group will receive rehabilitation immediately after an acute care at the neurological clinic (8 days) and one group 5 weeks after the insult. Patients practise walking every workday for 60 min (actual 30min) either on a treadmill or on a gait trainer for four weeks, and receive also other physiotherapy. In addition to selected parameters measuring brain plasticity, detailed assessments of functional abilities including motor ability and quality of life will be performed. A novel tool, MR-image navigated transcranial magnetic stimulation (TMS) is utilized in assessing cortical excitability in relation to stroke, time, rehabilitation, and recovery.

Conditions
Stroke
Being tested
gait-oriented rehabilitation
Keywords
stroke, rehabilitation, gait, timing, transcranial magnetic stimulation
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • gait-oriented rehabilitationOther

    Patients practise walking every workday for 60 min (actual 30min) either on a treadmill or on a gait trainer for four weeks, and receive also other physiotherapy 60 min daily.Patients starts within 10 days since stroke onset.

  • gait-oriented rehabilitationOther

    Patients practise walking every workday for 60 min (actual 30min) either on a treadmill or on a gait trainer for four weeks, and receive also other physiotherapy 60 min daily.Patients starts five weeks after stroke onset.

Study groups in NCT00849303
Study groupRoleWhat they receive
earlier gait-oriented rehabilitationExperimentalPatients practise walking every workday for 60 min (actual 30min) either on a treadmill or on a gait trainer for four weeks, and receive also other physiotherapy 60 min daily.
Receives: Other: gait-oriented rehabilitation
later gait-oriented rehabilitationActive comparatorPatients practise walking every workday for 60 min (actual 30min) either on a treadmill or on a gait trainer for four weeks, and receive also other physiotherapy 60 min daily.
Receives: Other: gait-oriented rehabilitation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Functional Ambulatory Category

    Measured: 4 measures during six months

  2. Barthel Index

    Measured: 4 measures during 6 months

Secondary outcomes (11)
  1. 10 meters's walking speed

    Measured: 4 measures during 6 months

  2. 6 minutes' walking distance

    Measured: 4 measures during 6 months

  3. Berg Balance Scale

    Measured: 4 measures during 6 months

  4. Functional Status Questionnaire

    Measured: 4 measures during 6 months

  5. Geriatric Depression Scale -15

    Measured: 4 measures during 6 months

  6. Beck Depression Intervention modified by Raitasalo

    Measured: 4 measures during 6 months

  7. Modified Motor Assessment Scale

    Measured: 4 measures during 6 months

  8. Postural sway by Good Balance

    Measured: 3-4 measures during 6 months

  9. spatio-temporal gait analysis by GaitRite

    Measured: 3-4 measures during 6 months

  10. WHOQOF-BREF

    Measured: at end and at 6 months' follow-up

  11. TMS responses (MT,MEPs,SP,SICI)

    Measured: 4 measures during 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Feb 2009 (estimated)
  2. Study startJan 2009
  3. Primary completionDec 2011 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2/3
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Care provider, Outcomes assessor
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00849303
Sponsor's protocol ID
5772765
Other IDs
Academy of Finland 114291
Status last verified
Feb 2009
First submitted
20 Feb 2009
Last updated
23 Feb 2009
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A Phase 2/3 study testing gait-oriented rehabilitation in people with Stroke, run by University of Jyvaskyla at 4 sites in Finland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 23 Feb 2009. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in Finland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Sinikka H Peurala, PhD, PT (+358 14 260 2196, sinikka.h.peurala@jyu.fi), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Functional Ambulatory Category (time frame: 4 measures during six months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Feb 2009.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in